|‘Cancer associated fibroblasts’–more than meets the eye|
S Madar, I Goldstein, V Rotter
Trends in molecular medicine 19 (8), 447-453, 2013
|p53‐repressed miRNAs are involved with E2F in a feed‐forward loop promoting proliferation|
R Brosh, R Shalgi, A Liran, G Landan, K Korotayev, GH Nguyen, E Enerly, ...
Molecular systems biology 4 (1), 229, 2008
|Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies|
I Goldstein, V Marcel, M Olivier, M Oren, V Rotter, P Hainaut
Cancer gene therapy 18 (1), 2-11, 2011
|Steroid receptors reprogram FoxA1 occupancy through dynamic chromatin transitions|
EE Swinstead, TB Miranda, V Paakinaho, S Baek, I Goldstein, M Hawkins, ...
Cell 165 (3), 593-605, 2016
|TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model|
O Leshem, S Madar, I Kogan-Sakin, I Kamer, I Goldstein, R Brosh, ...
PloS one 6 (7), e21650, 2011
|Regulation of lipid metabolism by p53–fighting two villains with one sword|
I Goldstein, V Rotter
Trends in Endocrinology & Metabolism 23 (11), 567-575, 2012
|Modulated expression of WFDC1 during carcinogenesis and cellular senescence|
S Madar, R Brosh, Y Buganim, O Ezra, I Goldstein, H Solomon, I Kogan, ...
Carcinogenesis 30 (1), 20-27, 2009
|Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species|
E Kalo, I Kogan-Sakin, H Solomon, E Bar-Nathan, M Shay, Y Shetzer, ...
Journal of cell science 125 (22), 5578-5586, 2012
|Various p53 mutant proteins differently regulate the Ras circuit to induce a cancer-related gene signature|
H Solomon, Y Buganim, I Kogan-Sakin, L Pomeraniec, Y Assia, S Madar, ...
Journal of Cell Science 125 (13), 3144-3152, 2012
|p53, a novel regulator of lipid metabolism pathways|
I Goldstein, O Ezra, N Rivlin, A Molchadsky, S Madar, N Goldfinger, ...
Journal of hepatology 56 (3), 656-662, 2012
|p53 Regulates the Ras circuit to inhibit the expression of a cancer-related gene signature by various molecular pathways|
Y Buganim, H Solomon, Y Rais, D Kistner, I Nachmany, M Brait, S Madar, ...
Cancer research 70 (6), 2274-2284, 2010
|p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production|
I Goldstein, K Yizhak, S Madar, N Goldfinger, E Ruppin, V Rotter
Cancer & metabolism 1 (1), 1-6, 2013
|A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype|
Y Buganim, I Goldstein, D Lipson, M Milyavsky, S Polak-Charcon, ...
PloS one 5 (3), e9657, 2010
|The role of the p53 tumor suppressor in metabolism and diabetes|
CP Kung, ME Murphy
The Journal of endocrinology 231 (2), R61, 2016
|Transcriptional and chromatin regulation during fasting–the genomic era|
I Goldstein, GL Hager
Trends in Endocrinology & Metabolism 26 (12), 699-710, 2015
|Chemotherapeutic agents induce the expression and activity of their clearing enzyme CYP3A4 by activating p53|
I Goldstein, N Rivlin, O Shoshana, O Ezra, S Madar, N Goldfinger, ...
Carcinogenesis 34 (1), 190-198, 2013
|Transcriptional activity of ATF3 in the stromal compartment of tumors promotes cancer progression|
Y Buganim, S Madar, Y Rais, L Pomeraniec, E Harel, H Solomon, E Kalo, ...
Carcinogenesis 32 (12), 1749-1757, 2011
|Bivariate genomic footprinting detects changes in transcription factor activity|
S Baek, I Goldstein, GL Hager
Cell reports 19 (8), 1710-1722, 2017
|Transcription factor assisted loading and enhancer dynamics dictate the hepatic fasting response|
I Goldstein, S Baek, DM Presman, V Paakinaho, EE Swinstead, GL Hager
Genome research 27 (3), 427-439, 2017
|The human 1‐8D gene (IFITM2) is a novel p53 independent pro‐apoptotic gene|
V Daniel‐Carmi, E Makovitzki‐Avraham, EM Reuven, I Goldstein, N Zilkha, ...
International journal of cancer 125 (12), 2810-2819, 2009